Vitafoods Steering Committee

PharmaLinea has been selected into the group of the industry’s leading companies that form the Vitafoods Europe Steering Committee.

our values & expertise recognized.

The Committee is formed through a strict selection process, where companies are evaluated on their values, mission within the nutraceutical space and capacity for consultancy on a level of industry-leading experts. PharmaLinea has demonstrated the potential to contribute to the Committee’s purpose of moving both Vitafoods and the industry forward and was thus offered a space in the organization. Accepting this great recognition of our company’s position, Chairman & Founder Blaž Gorjup will represent PharmaLinea and work collaboratively with other leading companies to shape the future of the nutraceutical industry.

Gorjup’s words on PharmaLinea’s objectives as a member of the Vitafods Steering Committee were:

“Our mission aligns with the Committee’s and I believe our expertise can contribute greatly to improving the Vitafoods show floor and making the industry better for consumers. We wish to be one of the active and vocal representatives of the nutraceutical industry, putting forth proposals for projects, while providing all the insight at our disposal. Priorities on our agenda include projects promoting connectivity throughout the entire supply chain and educating on the topic of finished product stability and clinical substantiation.”

The highest growth for the next 5 years is expected for Thailand and Vietnam, while the more mature market of South Korea is projected to exhibit less growth. However, the latter is already nearly 4 times the size of the UK market.


{Your} Iron Syrup’s efficiency was confirmed in a gold-standard clinical trial encompassing 50 children. Upon administration of our product for 12 months, ferritin levels were icreased by 56% when compared to placebo.

indications, forms & plans.

Klopčič went on to add: “The top-performing categories vary significantly from market to market, but the most common to take top positions are immune system, bone health, cognitive health, beauty and other health areas. The latter is a category where we often find products such as the ones addressing iron deficiency, where we are specialists. Our iron line has been in high demand because iron deficiency is typically more problematic in the region and the available solutions often come with drawbacks such as low absorption and side effects.

With markets evolving faster and faster and consumers in Southeast Asia demanding more and more from their supplement user experience, we are increasingly partnering with companies in the region by providing them with supplements in liquids, sachets, sprays, and other user-friendly product forms. Not to dismiss more traditional, yet still successful capsules and tablets.

We are currently working in Vietnam and South Korea and we are in various stages of registration processes in Indonesia, Malaysia, and the Philippines. We have already seen 100% growth in business from Southeast Asia last year and we project the growth to rise to more than 150% with the launch of more products.”

This year we are expecting results of two clinical trials –
on our immunity and iron supplements.

The trials were designed according to gold standards and with them, we plan to fill the gaps in the two segments by providing our clients with clearly differentiated products and clinically proven efficacy. We are also successfully developing business in the region with solutions addressing sleep and prenatal supplementation.

In our view, the only way to get lasting consumer trust is to provide supplements with benefits one can feel and prove.

reach out.

  • Max. file size: 30 MB.

PharmaLinea © 2024